Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well giving cisplatin together with flavopiridol works in
treating patients with advanced ovarian epithelial cancer or primary peritoneal cancer. Drugs
used in chemotherapy, such as cisplatin and flavopiridol, work in different ways to stop
tumor cells from dividing so they stop growing or die. Combining more than one drug may kill
more tumor cells.